Hjem › Brystkreft › Washington › Tacoma
Kliniske studier for Brystkreft i Tacoma, WA
18 studier for Brystkreft søker deltakere på steder i og rundt Tacoma (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruttererFrivillige helsepersonell ønskes velkommen
- Madigan Army Medical Center, Tacoma
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RekruttererFase 3
- Northwest Medical Specialties, Tacoma
- Providence Regional Cancer System, Lacey · 23 mi unna
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Providence Regional Cancer System-Lacey, Lacey · 23 mi unna
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
RekruttererFase 3
- Research Site, Puyallup · 8 mi unna
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
RekruttererFase 2
- Northwest Medical Specialties, Puyallup · 8 mi unna
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
RekruttererFase 3
- Northwest Medical Specialties, PLLC ( Site 0062), Tacoma
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekruttererFase 3
- Research Site, Tacoma
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RekruttererFase 3
- Northwest Medical Specialties, Tacoma
- Northwest Medical Specialties, Gig Harbor · 8 mi unna
- Northwest Medical Specialties, Puyallup · 8 mi unna
- og 1 flere
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekruttererFase 3
- Northwest Medical Specialties, PLLC ( Site 0067), Tacoma
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Rekrutterer
- MultiCare Cancer Institute, Tacoma
- Northwest Medical Specialties, PLLC, Puyallup · 8 mi unna
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RekruttererFase 3
- Clinical Trial Site, Olympia · 26 mi unna
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruttererFase 3
- MultiCare Health System, Tacoma
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekruttererFase 3
- Northwest Medical Specialties, PLLC, Tacoma
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruttererFase 3
- MultiCare Cancer Institute - Tacoma, Tacoma
- Northwest Medical Specialties PLLC, Tacoma
- Vista Oncology, Olympia · 26 mi unna
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RekruttererFase 3
- Northwest Medical Specialties, Tacoma
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- Providence Regional Cancer System-Lacey, Lacey · 23 mi unna
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
RekruttererFase 1/2
- Northwest Medical Specialties, PLLC, Tacoma
BostonGene and Exigent Genomic INsight Study
RekruttererObservasjonsstudie
- Northwest Medical Specialities, Puyallup · 8 mi unna
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Tacoma
- Ikke-småcellet lungekreft20 studier
- Ulcerøs kolitt15 studier
- Multipelt myelom13 studier
- Prostatakreft11 studier
- Crohns sykdom11 studier
- Kolorektal kreft9 studier
- Metastatisk kreft9 studier
- Melanom7 studier
- Eggstokkreft7 studier
- Mavekreft6 studier
- Spiserørkreft6 studier
- Kreft (alle typer)6 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.